IGM Biosciences Inc.

NASDAQ: IGMS · Real-Time Price · USD
1.27
0.00 (0.00%)
At close: Aug 13, 2025, 3:59 PM
1.28
0.79%
After-hours: Aug 13, 2025, 06:49 PM EDT

IGM Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-195.79M -246.42M -221.1M -165.16M
Depreciation & Amortization
9.11M 8.28M 6.08M 4.48M
Stock-Based Compensation
38.27M 46.55M 44.71M 25.87M
Other Working Capital
-6.8M -5.7M 158.17M 5.79M
Other Non-Cash Items
2.53M 6.05M 9.29M 3.24M
Deferred Income Tax
n/a n/a n/a 781K
Change in Working Capital
-7.11M -6.69M 155.17M 6.45M
Operating Cash Flow
-153M -192.23M -5.85M -124.34M
Capital Expenditures
-5.85M -12.38M -10.21M -13.24M
Cash Acquisitions
n/a n/a 7.37M -28.7M
Purchase of Investments
-219.43M -365.04M -540.02M -129.35M
Sales Maturities Of Investments
289.4M 445.77M 324.58M 157.41M
Other Investing Acitivies
39K n/a -7.37M 28.7M
Investing Cash Flow
64.16M 68.36M -225.64M 14.82M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a -1.55M
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
2.39M 1.5M 1.4M 2.48M
Financial Cash Flow
2.39M 115.07M 219.38M 2.48M
Net Cash Flow
-86.45M -8.81M -12.12M -107.05M
Free Cash Flow
-158.85M -204.61M -16.06M -137.58M